DOSSIER · 13F-HR · Q2 2026

Tao Capital Management LP

$1.9B in tracked AUM across 6 positions as of Q2 2026.

TC
CIK 0001802967 · last filed Jun 30, 2026
Total AUM
$1.9B
as of Q2 2026
Holdings
6
—
positions
Whale Score
77
77
strong
Activity
—
no data
changes this Q
AI Analysis · Q2 2026

Based on the SEC 13F filing for Tao Capital Management LP for the period ending September 30, 2025, here is a comprehensive financial analysis.

1. Portfolio Overview

Tao Capital Management LP manages a highly concentrated portfolio valued at approximately $103.46 million, representing a significant decrease of 24.1% from the previous quarter's $136.37 million. This reduction in value is attributable to a combination of asset reallocation and potential market depreciation in existing hol...

2. Key Holdings

The portfolio is dominated by three major positions, each representing a significant bet on specific sectors:

  • Tesla, Inc. (TSLA): As the largest holding, TSLA comprises 37.07% of the portfolio ($38.36 million). Despite the reduction in overall portfolio value, the share count remained unchanged at 86,000 shares, suggesting the firm maintained its conviction in the consumer cyclical giant throughout the quarter.
  • Ouster, Inc. (OUST): Ouster is the second-largest holding, representing 29.42% of the portfolio ($30.44 million). With 1.13 million shares held, this technology stock indicates a strong focus on the lidar and autonomous driving sector. The stability of the share count (1 of 7 unchanged positions) suggests no profit-taking or accumulation occurred despite market fluctuations.
  • Twist Bioscience Corporation (TWST): This healthcare position occupies 22.54% of the portfolio ($23.32 million). With 829,000 shares, Tao Capital maintains a substantial stake in the synthetic biology and genomics space.

3. Sector Allocation

The portfolio displays a distinct sector tilt with little regard for traditional defensive diversification.

  • Consumer Cyclical (37.07%): Entirely represented by Tesla, this sector provides the portfolio's largest exposure.
  • Technology (29.42%): Driven primarily by Ouster, this allocation highlights a focus on innovative hardware and sensing technologies.
  • Healthcare (29.50%): This sector is surprisingly well-represented relative to the portfolio size, driven by Twist Bioscience (22.54%), Warby Parker (3.58%), and the new position in 10x Genomics (2.38%).
  • Unknown (5.00%): A small portion of the portfolio is allocated to holdings not clearly categorized in the standard sectors (908 Devices, Sonder Holdings, and Ginkgo Bioworks).
Analysis generated by 13F Insight from SEC Form 13F filing data · Q2 2026. Methodology

Quarter at a glance — Q2 2026

Position-change comparison pending.

No quarter-over-quarter changes available.

Top 10 holdings

By portfolio weight as of Q2 2026.

#HoldingValueSharesWeight
01
SPCX
Space Exploration Technologies Corp.
$1.8B10.6M93.7%
02
TWST
Twist Bioscience Corporation
$49M479K2.5%
03
TSLA
Tesla, Inc.
$36M86K1.9%
04
H
Hyatt Hotels Corporation
$14M70K0.7%
05
MDGL
Madrigal Pharmaceuticals, Inc.
$11M21K0.6%
06
TXG
10x Genomics, Inc.
$11M283K0.6%

Filing history

2026Q2Jun 30
$1.9B▲ 1532.6%
6 positionsView →
2026Q1Mar 31
$119M▲ 2.3%
8 positionsView →
2025Q4Dec 31
$116M▲ 12.3%
8 positionsView →
2025Q3Sep 30
$103M▼ 24.1%
8 positionsLocked
2025Q2Jun 30
$136M▲ 94.3%
9 positionsLocked
2025Q1Mar 31
$70M▼ 51.0%
7 positionsLocked
2024Q4Dec 31
$143M▲ 29.8%
10 positionsLocked
2024Q3Sep 30
$110M▼ 9.5%
10 positionsLocked
2024Q2Jun 30
$122M▲ 15.6%
10 positionsLocked
2024Q1Mar 31
$106M▼ 3.4%
10 positionsLocked
2023Q4Dec 31
$109M▼ 15.3%
12 positionsLocked
2023Q3Sep 30
$129M▼ 5.4%
11 positionsLocked
Showing 12 of 27